AlphaGrep UK’s Linde LIN Stock Holding History

AlphaGrep UK’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-561	Closed	-$278K	–	853
2026 Q1	$278K	Buy	561 +7	+1%	+$3.3K	0.08%	550
2025 Q4	$236K	Buy	+554	New	+$237K	0.08%	558

Other funds holding LIN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AlphaGrep UK's LIN Position: Q2 2026 in Review

AlphaGrep UK sold out of Linde (LIN) in Q2 2026, closing a stake of 561 shares — an estimated $278K sold.

AlphaGrep UK first reported a position in LIN in Q4 2025 and held it in 2 quarters. The position peaked at $278K in Q1 2026. 2,251 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

AlphaGrep UK reported no remaining Linde position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 561 Linde shares in Q2 2026, an estimated $278K.
AlphaGrep UK first reported a position in Linde in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Linde position peaked at $278K in Q1 2026.
2,251 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.